A detailed history of Cva Family Office, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cva Family Office, LLC holds 3,529 shares of AMGN stock, worth $1.13 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,529
Previous 2,926 20.61%
Holding current value
$1.13 Million
Previous $831,000 32.61%
% of portfolio
0.2%
Previous 0.15%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$262.75 - $319.31 $158,438 - $192,543
603 Added 20.61%
3,529 $1.1 Million
Q1 2024

Apr 10, 2024

BUY
$268.87 - $324.56 $268 - $324
1 Added 0.03%
2,926 $831,000
Q4 2023

Jan 16, 2024

BUY
$255.7 - $288.46 $68,271 - $77,018
267 Added 10.05%
2,925 $842,000
Q3 2023

Oct 11, 2023

SELL
$218.65 - $271.46 $28,643 - $35,561
-131 Reduced 4.7%
2,658 $714,000
Q2 2023

Jul 10, 2023

BUY
$214.27 - $253.37 $102,849 - $121,617
480 Added 20.79%
2,789 $619,000
Q1 2023

Apr 26, 2023

SELL
$225.79 - $275.2 $21,224 - $25,868
-94 Reduced 3.91%
2,309 $558,000
Q4 2022

Feb 21, 2023

SELL
$229.03 - $291.01 $1,145 - $1,455
-5 Reduced 0.21%
2,403 $631,000
Q3 2022

Nov 22, 2022

BUY
$224.46 - $253.15 $206,727 - $233,151
921 Added 61.94%
2,408 $543,000
Q2 2022

Jul 11, 2022

BUY
$230.71 - $256.74 $14,996 - $16,688
65 Added 4.57%
1,487 $362,000
Q1 2022

Apr 22, 2022

BUY
$219.27 - $242.57 $75,648 - $83,686
345 Added 32.03%
1,422 $344,000
Q4 2021

Jan 25, 2022

BUY
$198.88 - $227.6 $128,078 - $146,574
644 Added 148.73%
1,077 $242,000
Q3 2021

Oct 12, 2021

SELL
$212.27 - $248.7 $149,438 - $175,084
-704 Reduced 61.92%
433 $110,000
Q2 2021

Jul 13, 2021

BUY
$233.58 - $259.14 $31,299 - $34,724
134 Added 13.36%
1,137 $277,000
Q1 2021

Apr 14, 2021

BUY
$221.91 - $258.6 $126,488 - $147,402
570 Added 131.64%
1,003 $250,000
Q2 2020

Jul 31, 2020

BUY
$197.81 - $242.74 $25,121 - $30,827
127 Added 41.5%
433 $102,000
Q1 2020

May 28, 2020

BUY
$182.24 - $241.7 $55,765 - $73,960
306 New
306 $62,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.